Clinical Performance of GYNECARE PROSIMA* Pelvic Floor Repair System for Symptomatic Pelvic Organ Prolapse
A Prospective, Multicenter Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Symptomatic POP-Q Stage II-III Pelvic Organ Prolapse
Sponsor: Peking Union Medical College Hospital
This NA trial investigates Pelvic Organ Prolapse and Stage II-III and is currently ongoing. Peking Union Medical College Hospital leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Aug 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jul 2018 — Aug 2018 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Changsha, China , Chengdu, China , Chongqin, China , Foshan, China , Fuzhou, China , Guangzhou, China , Harbin, China , Jinan, China , Mianyang, China and 6 more locations